Cargando…
Evaluation of the cobas(®) GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures
Direct-acting antiviral (DAA) drug performances depend on the viral genotype. So international recommendations give typing of the virus a prerequisite for treatment choice and patient management. Commercially available HCV genotyping kits are scarce and this analysis is often in-house using tedious...
Autores principales: | Némoz, Benjamin, Roger, Léa, Leroy, Vincent, Poveda, Jean-Dominique, Morand, Patrice, Larrat, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864039/ https://www.ncbi.nlm.nih.gov/pubmed/29566005 http://dx.doi.org/10.1371/journal.pone.0194396 |
Ejemplares similares
-
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018) -
The cobas(®) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice
por: Fernández-Caballero, J. A., et al.
Publicado: (2017) -
Evaluation of INNO-LiPA mycobacteria v2 assay for identification of rapidly growing mycobacteria
por: García-Agudo, Lidia, et al.
Publicado: (2011) -
Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates
por: Ali, Maisa M, et al.
Publicado: (2010) -
Comparison of Four Human Papillomavirus Genotyping Methods: Next-generation Sequencing, INNO-LiPA, Electrochemical DNA Chip, and Nested-PCR
por: Nilyanimit, Pornjarim, et al.
Publicado: (2018)